ÀÌ½Ä Áø´Ü ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµº°, Àå±â À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Transplant Diagnostics Market, By Product Type, By Technology, By Application, By Organ Type, By End User, By Geography
»óǰÄÚµå
:
1402674
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2023³â 12¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°è ÀÌ½Ä Áø´Ü ½ÃÀå ±Ô¸ð´Â 2023³â 9¾ï 6,630¸¸ ´Þ·¯¿¡¼ 2030³â¿¡´Â 16¾ï 7,700¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 8.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í ¹üÀ§ |
º¸°í¼ »ó¼¼ |
±âÁس⵵ |
2022³â |
2023³â ½ÃÀå ±Ô¸ð |
9¾ï 6,630¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2018-2021³â |
¿¹Ãø ±â°£ |
2023-2030³â |
¿¹Ãø ±â°£ÀÇ CAGR |
8.20% |
2030³â ½ÃÀå ±Ô¸ð Àü¸Á |
16¾ï 7,700¸¸ ´Þ·¯ |
±×¸² 1. 2023³â ÀÌ½Ä Áø´Ü ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°

ÀÌ½Ä Áø´Ü ºÐ¾ß´Â Àå±â ÀÌ½Ä ÀýÂ÷¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ Àå±â ¹× Á¶Á÷ À̽ÄÀÇ ÀûÇÕ¼º°ú ¼º°ø·üÀ» ³ôÀÌ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ½Ä Áø´Ü ¼¼°è ½ÃÀåÀº ±âÁõµÈ Àå±â ¹× Á¶Á÷°ú ¼öÇýÀÚÀÇ ¸é¿ª ü°èÀÇ ÀûÇÕ¼ºÀ» È®ÀÎÇÏ´Â µ¥ »ç¿ëµÇ´Â ±¤¹üÀ§ÇÑ ÀÇ·á ÀýÂ÷, ±â¼ú, °Ë»ç ¹× Àåºñ¿Í °ü·ÃµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ ÀÇÇÐ ºÐ¾ß´Â ÀÌ½Ä °ÅºÎ¹ÝÀÀÀÇ °¡´É¼ºÀ» ÁÙÀ̰í ÀÌ½Ä ÈÄ È¯ÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ½Ä Áø´Ü¿¡´Â Àΰ£ ¹éÇ÷±¸ Ç׿ø(HLA) ŸÀÌÇΰú °°Àº Á¶Á÷ ÀûÇÕ¼º °Ë»ç¸¦ Æ÷ÇÔÇÑ ÀÏ·ÃÀÇ °Ë»ç°¡ Æ÷ÇԵǸç, ÀÌ´Â ±âÁõÀÚ¿Í ¼öÇýÀÚ°¡ °¡Àå Àß ¸Â´ÂÁö È®ÀÎÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ´Â Àå±â °ÅºÎ¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â Ç×ü¸¦ Æò°¡Çϱâ À§ÇØ »ç¿ëµÇ´Â Ç÷ûÇÐÀû ¹× °Ô³ð ±â¹Ý ºÐ¼®¿¡ ÀÇÇØ µÞ¹ÞħµË´Ï´Ù. ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR) ¹× Â÷¼¼´ë ¿°±â¼¿ºÐ¼®(NGS)°ú °°Àº ÷´Ü ºÐÀÚÁø´Ü °Ë»ç´Â À¯ÀüÀÚ ¸ÅĪ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÏ¿© Àå±â ¸ÅĪ ¹× »ýÁ¸°¡´É¼º Æò°¡ÀÇ Á¤È®µµ¸¦ Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î Áø´Ü ±â¼úÀÇ ÃâÇö, Àå±â À̽ÄÀÌ ÇÊ¿äÇÑ ¾Ï°ú °°Àº ¸¸¼º ÁúȯÀÇ ¹ßº´·ü Áõ°¡, ÀÌ½Ä ¼ö¼ú °Ç¼ö Áõ°¡, ÀÌ·¯ÇÑ ÀÇ·á ÇàÀ§¿¡ ´ëÇÑ Àνİú ÀÚ±Ý Á¶´ÞÀÌ Áõ°¡ÇÏ¸é¼ ¼¼°è ÀÌ½Ä Áø´Ü ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î Áø´Ü °Ë»ç¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú Àå±â ±âÁõÀ» ÃËÁøÇÏ´Â ´Ù¾çÇÑ Á¤ºÎ ¹× ºñÁ¤ºÎ±â±¸ÀÇ Âü¿©µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¼ö¸¹Àº ÀÇ·á±â±â Á¦Á¶¾÷ü, Àü¹® Áø´Ü¼¾ÅÍ ¹× ¿¬±¸¼Ò°¡ Á¦°øÇÏ´Â ´Ù¾çÇÑ °Ë»ç ¼ºñ½º ¹× °Ë»ç Àåºñ·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, ±Þ¼º ¹× ¸¸¼º Àå±â ºÎÁ·À» ÇØ°áÇϰí È¿°úÀûÀÎ ÀÌ½Ä °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ÇâÈÄ ÀÌ½Ä Áø´Ü ½ÃÀåÀº Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß°ú ´õºÒ¾î °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ µµÀÔ Áõ°¡¿Í ½ÅÈï±¹ ½ÃÀåÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡·Î ÀÎÇØ ´õ¿í °ÈµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÷´Ü Áø´Ü ±â¼úÀÇ ÃâÇö°ú ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå°ú ÁøÈ¸¦ ÀÌ·ê °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
½ÃÀå ¿ªÇÐ
¼¼°è ÀÌ½Ä Áø´Ü ½ÃÀåÀº Àå±â ºÎÀü ¹ß»ý·ü Áõ°¡¿Í ¼¼°è Àå±â ÀÌ½Ä ¼ö¼ú Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â ¹Ì±¹¿¡¼ 42,887°ÇÀÇ Àå±â À̽ÄÀÌ ½ÃÇàµÇ¾î 2021³â ´ëºñ 3.7% Áõ°¡ÇÏ¿© ¿¬°£ ½Å±â·ÏÀ» ¼¼¿ü½À´Ï´Ù. ¿¬¹æ Á¤ºÎÀÇ °è¾à¿¡ µû¶ó Àü±¹ Àå±â Á¶´Þ ¹× ÀÌ½Ä ³×Æ®¿öÅ© ¿ªÇÒÀ» ÇÏ´Â Àå±â ÀÌ½Ä ³×Æ®¿öÅ©(UNOS)ÀÇ ¼Óº¸ µ¥ÀÌÅÍ¿¡ µû¸£¸é.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- ÀÌ Á¶»ç º¸°í¼´Â 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð¿Í CAGRÀ» Á¦½ÃÇÏ´Â ¼¼°è ÀÌ½Ä Áø´Ü ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù.
- ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
- ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á »çÇ×µµ Á¦°øÇÕ´Ï´Ù.
±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ÀÌ½Ä Áø´Ü ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
- ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
- ÀÌ º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
- ÀÌÇØ°ü°èÀÚ´Â ¼¼°è ÀÌ½Ä Áø´Ü ÀǾàǰ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
- º¸°í¼ ¼³¸í
- ÁÖ¿ä ¿ä¾à
- Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- ±âȸ
- ¿µÇ⠺м®
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- ±ÔÁ¦ ½Ã³ª¸®¿À
- Á¦Ç° ¹ß¸Å/½ÂÀÎ
- PEST ºÐ¼®
- PorterÀÇ Five Forces ºÐ¼®
- ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
Á¦4Àå ¼¼°èÀÇ ÀÌ½Ä Áø´Ü ½ÃÀå, Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ
- ½ÅÇü Äڷγª¹ÙÀÌ·¯½º(COVID-19) ¿ªÇÐ
- °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
- °æÁ¦Àû ¿µÇâ
Á¦5Àå ¼¼°èÀÇ ÀÌ½Ä Áø´Ü ½ÃÀå, Á¦Ç° À¯Çüº°, 2018-2030³â
- ±â±¸
- ½Ã¾à ¹× ŰƮ
- ¼ÒÇÁÆ®¿þ¾î
Á¦6Àå ¼¼°èÀÇ ÀÌ½Ä Áø´Ü ½ÃÀå, ±â¼úº°, 2018-2030³â
- ºÐÀÚ ¾î¼¼ÀÌ
- ºñºÐÀÚ ¾î¼¼ÀÌ
Á¦7Àå ¼¼°èÀÇ ÀÌ½Ä Áø´Ü ½ÃÀå, ¿ëµµº°, 2018-2030³â
- Á¶Á÷ ŸÀÌÇÎ
- °¨¿°Áõ °Ë»ç
- Ç÷û ±³Â÷ ¸ÅĪ
- Ç÷¾× ÇÁ·ÎÆÄÀϸµ
Á¦8Àå ¼¼°èÀÇ ÀÌ½Ä Áø´Ü ½ÃÀå, Àå±â À¯Çüº°, 2018-2030³â
- ½ÅÀå
- °£
- ½ÉÀå
- Æó
- ̎ˌ
- ±âŸ
Á¦9Àå ¼¼°èÀÇ ÀÌ½Ä Áø´Ü ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2018-2030³â
- º´¿ø ¹× À̽ļ¾ÅÍ
- ¿¬±¸±â°ü ¹× Çмú±â°ü
- »ó¿ë ¼ºñ½º Á¦°ø¾÷ü
Á¦10Àå ¼¼°èÀÇ ÀÌ½Ä Áø´Ü ½ÃÀå, Áö¿ªº°, 2018-2030³â
- ºÏ¹Ì
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ½ºÆäÀÎ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ASEAN
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- GCC ±¹°¡
- À̽º¶ó¿¤
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- Áß¾Ó¾ÆÇÁ¸®Ä«
- ºÏ¾ÆÇÁ¸®Ä«
Á¦11Àå °æÀï ±¸µµ
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Hoffman-La Roche Ltd.
- Immucor, Inc.
- Becton Dickinson and Company
- bioMerieux S.A.
- Illumina, Inc.
- CareDx, Inc.
- GenDx
Á¦12Àå ¼½¼Ç
LSH
¿µ¹® ¸ñÂ÷
The global transplant diagnostics market size is expected to reach US$ 1,677 Mn by 2030, from US$ 966.3 Mn in 2023, at a CAGR of 8.2% during the forecast period.
Report Coverage |
Report Details |
Base Year: |
2022 |
Market Size in 2023: |
US$ 966.3 Mn |
Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: |
8.20% |
2030 Value Projection: |
US$ 1,677 Mn |
Figure 1. Global Transplant Diagnostics Market Share (%), by Region, 2023

The field of transplant diagnostics has been instrumental in revolutionizing organ transplant procedures, enhancing the compatibility and success rate of organ and tissue grafts. The global market for transplant diagnostics pertains to the extensive range of medical procedures, technologies, tests, and equipment used to ascertain the compatibility of donated organs and tissues with the recipient's immune system. This branch of medical science plays a critical role in reducing the likelihood of transplant rejection and improving patient outcomes post-transplantation. Transplant diagnostics involve a series of tests that include histocompatibility testing, such as human leukocyte antigens (HLA) typing, which is pivotal in ensuring the most compatible match between donor and recipient. This is further supported by serological and genome-based assays used to assess antibodies that may cause organ rejection. Advanced molecular diagnostic tests such as polymerase chain reaction (PCR) and Next-Generation Sequencing (NGS) offer detailed insights into the genetic matching, improving the precision of organ matches and viability assessments. Furthermore, the emergence of new diagnostic technologies, the increasing incidence of chronic diseases such as cancer, necessitating organ transplants, a growing number of transplantation procedures, and heightened awareness and funding for such medical practices have contributed to the expansion of the global transplant diagnostics market. Additionally, regulatory approvals for new diagnostic tests, along with the involvement of various government and non-governmental organizations in promoting organ donation, are factors driving market growth. The market comprises various testing services and instruments provided by numerous medical device companies, specialty diagnostic centers, and research labs, addressing acute and chronic organ shortages and ensuring effective transplant outcomes. Moving forward, the continued research and development, coupled with the rising adoption of personalized medicine and increased healthcare spending in developing countries, are expected to bolster the transplant diagnostics market further. With the advent of sophisticated diagnostic technologies and a growing emphasis on preventive healthcare, the market is set for continued growth and evolution.
Market Dynamics:
The global transplant diagnostics market is driven by the rising incidence of organ failure and increasing organ transplantation procedures worldwide. For instance, in 2022, 42,887 organ transplants were performed in the U.S., an increase of 3.7 percent over 2021 and a new annual record, according to preliminary data from the United Network for Organ Sharing (UNOS), which serves as the national Organ Procurement and Transplantation Network under federal contract.
Key Features of the Study:
- This report provides an in-depth analysis of the global transplant diagnostics market, and provides market size (US$ Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global transplant diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffman-La Roche Ltd., Immucor, Inc., Becton Dickinson and Company, bioMerieux S.A., Illumina, Inc., CareDx, Inc., and GenDx.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics
- The global transplant diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transplant diagnostics market
Global Transplant Diagnostics Market Segmentation:
- By Product Type
- Instrument
- Reagents & Kits
- Software
- By Technology
- Molecular Assay
- Non-Molecular Assay
- By Application
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- By Organ Type
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- By End User
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Top Companies in the Global Transplant Diagnostics Market
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Hoffman-La Roche Ltd.
- Immucor, Inc.
- Becton Dickinson and Company
- bioMerieux S.A.
- Illumina, Inc.
- CareDx, Inc.
- GenDx
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Transplant Diagnostics, By Product Type
- Market Transplant Diagnostics, By Technology
- Market Transplant Diagnostics, By Application
- Market Transplant Diagnostics, By Organ Type
- Market Transplant Diagnostics, By End User
- Market Transplant Diagnostics, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising number of organ transplantation
- High cost of transplant diagnostic tests
- Point-of-care transplant diagnostics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Transplant Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Transplant Diagnostics Market, By Product Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Instrument
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
6. Global Transplant Diagnostics Market, By Technology, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Molecular Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Non-Molecular Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
7. Global Transplant Diagnostics Market, By Application, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Tissue Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Serum-Cross Matching
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Blood Profiling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
8. Global Transplant Diagnostics Market, By Organ Type , 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Kidney
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Liver
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Heart
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Pancreas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
9. Global Transplant Diagnostics Market, By End User, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals & Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Research Laboratories & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Commercial Service Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
10. Global Transplant Diagnostics Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 - 2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
- South Africa
- Central Africa
- North Africa
11. Competitive Landscape
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Hoffman-La Roche Ltd.
- Immucor, Inc.
- Becton Dickinson and Company
- bioMerieux S.A.
- Illumina, Inc.
- CareDx, Inc.
- GenDx
- Analyst Views
12. Section
- Research Methodology
- About us
°ü·ÃÀÚ·á